$22.38
0.02[0.09%]
At close: Apr 29
$22.38
0[0.00%]
After Hours: 5:20PM EDT
Landos Biopharma
(NASDAQ:LABP)Landos Biopharma Stock (NASDAQ:LABP), Quotes and News Summary
Landos Biopharma Stock (NASDAQ: LABP) stock price, news, charts, stock research, profile.
| Open | $22.130 |
| Close | $22.330 |
| Volume / Avg. | 10.749K / 24.855K |
| Day Range | 22.130 - 22.375 |
| 52 Wk Range | 2.500 - 22.840 |
| Market Cap | $69.808M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 83 |
| Short Interest | 0.05% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Landos Biopharma (LABP) stock?
You can purchase shares of Landos Biopharma (NASDAQ: LABP) through any online brokerage.
Who are Landos Biopharma's (LABP) competitors?
Other companies in Landos Biopharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).
What is the target price for Landos Biopharma (LABP) stock?
The latest price target for Landos Biopharma (NASDAQ: LABP) was reported by HC Wainwright & Co. on Monday, April 1, 2024. The analyst firm set a price target for 20.42 expecting LABP to fall to within 12 months (a possible -8.76% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Landos Biopharma (LABP)?
The stock price for Landos Biopharma (NASDAQ: LABP) is $22.38 last updated April 29, 2024 at 5:20 PM EDT.
Does Landos Biopharma (LABP) pay a dividend?
There are no upcoming dividends for Landos Biopharma.
When is Landos Biopharma (NASDAQ:LABP) reporting earnings?
Landos Biopharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Landos Biopharma (LABP) going to split?
There is no upcoming split for Landos Biopharma.
What sector and industry does Landos Biopharma (LABP) operate in?
Landos Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.